Vitiligo
Not recruitingStudy on MK-6194 for Treating Adults with Non-Segmental Vitiligo
Study on MK-6194 for Treating Adults with Non-Segmental Vitiligo
Spain- Participants:18–64 years · 65+ years
- Substances:MK-6194
- Sponsor:Merck Sharp & Dohme LLC
Rare diseases
Investigational molecules
Locations
Back to Spain3 741 clinical trials in Sabadell, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on MK-6194 for Treating Adults with Non-Segmental Vitiligo
SpainStudy on Reducing Tacrolimus in Kidney Transplant Patients with Low Immunological Risk Using Tacrolimus, Mycophenolic Acid, and Prednisone
SpainStudy on the Safety of Human Serum Albumin and Enoxaparin in Patients with Decompensated Cirrhosis at High Risk of Poor Outcome
SpainStudy on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria
SpainStudy of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer
SpainStudy on Pembrolizumab and Lenvatinib for Patients with Pre-Treated Thymic Carcinoma and B3-Thymoma
SpainStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
SpainStudy of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment
SpainStudy of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant
SpainStudy Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
SpainStudy Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer
SpainStudy to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Acute Respiratory Distress Syndrome (ARDS) and advanced lung cancer treatments. Studies evaluating new therapeutic approaches for non-small cell lung cancer, including combination therapies with immunotherapy agents.
Comprehensive research into various cancer types, including bladder cancer and prostate cancer. Studies examining novel combination therapies and investigating new treatment approaches for both early-stage and metastatic conditions.
Groundbreaking research in autoimmune disorders including Sjögren's Syndrome and Systemic Sclerosis. Studies evaluating novel biological therapies and investigating long-term treatment outcomes for chronic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.